Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr;115(2):111-116.
doi: 10.32074/1591-951X-873.

Placental site trophoblastic tumor (PSTT): a case report and review of the literature

Affiliations
Review

Placental site trophoblastic tumor (PSTT): a case report and review of the literature

Claudia Zampacorta et al. Pathologica. 2023 Apr.

Abstract

Placental site trophoblastic tumor (PSTT), also known as atypical choriocarcinoma, syncytioma, chorioepitheliosis or trophoblastic pseudotumor, is a rare gestational trophoblastic disease (0.25-5% of all trophoblastic tumors) and it is composed by neoplastic proliferation of intermediate trophoblasts at placental implantation site. It consists of aggregates or sheets of large, polyhedral to round, predominantly mononucleated cells with a characteristic vascular and myometrial invasion. Main differential diagnoses are gestational choriocarcinoma (GC) and epitelioid trophoblastic tumor (ETT). We present a case of PSTT in a 25-year-old woman. Neoplastic cells showed moderate/high nuclear pleomorphism, abundant amphophilic, eosinophilic and clear cytoplasm, numerous mitotic figures (10 mitoses/10 HPF), and myometrial invasion. Other features are necrosis, vascular invasion with replacement of myometrial vessels by tumor cells and hemorrhage. The patient showed typical low serum β-hCG levels and high serum humane placental lactogen (hPL) levels.

Keywords: HPL; Intermediate trophoblast; gestational trophoblastic disease; placental site trophoblastic tumor.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
(A-B) Opened hysterectomy specimen containing placental site trophoblastic tumor (PSTT). The cut surface shows a pale-tan fleshy and hemorrhagic mass arising from the endomyometrium.
Figure 2.
Figure 2.
(A-D) Microscopic analysis reveals coagulative tumor cell necrosis (A), hemorrhagic areas (B), neoplastic intermediate trophoblasts infiltrating myometrium by separating individual muscle fibers (C) and vascular invasion with replacement of myometrial vessels by tumor cells (D).
Figure 3.
Figure 3.
(A-D) Vascular invasion pattern recapitulates that of normal implantation trophoblast: the tumor cells replace the wall of myometrial vessels and these transformed blood vessels allowed PSTT diagnosis (A,B). At higher magnification, there is a cellular proliferation of neoplastic intermediate trophoblast cells, characterized by abundant amphophilic, eosinophilic or clear cytoplasm, variable nuclear size and shape with marked hypercromasia, nuclear grooves, pseudoinclusions, prominent nucleoli and several mitoses (green arrowhead) (C,D).
Figure 4.
Figure 4.
(A-D) Immunohistochemical profile shows a high proliferative index (Ki-67>30%) (A,B) and diffuse and strong cytoplasm staining for hPL confirming PSTT diagnosis (C,D).

References

    1. Hui P. Gestational Trophoblastic Tumors: A Timely Review of Diagnostic Pathology. Arch Pathol Lab Med 2019;143:65-74. https://doi.org/10.5858/arpa.2018-0234-RA. Epub 2018 Nov 8. 10.5858/arpa.2018-0234-RA PMID: . - DOI - PubMed
    1. Clark JJ, Slater S, Seckl MJ. Treatment of gestational trophoblastic disease in the 2020s. Curr Opin Obstet Gynecol 2021;33:7-12. https://doi.org/10.1097/GCO.0000000000000674. 10.1097/GCO.0000000000000674 PMID: ; PMCID: . - DOI - PMC - PubMed
    1. Feng X, Wei Z, Zhang S, Du Y, Zhao H. A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors. Front Oncol 2019;9:937. https://doi.org/10.3389/fonc.2019.00937 10.3389/fonc.2019.00937 PMID: ; PMCID: . - DOI - PMC - PubMed
    1. Sharami SRY, Saffarieh E. A review on management of gestational trophoblastic neoplasia. J Family Med Prim Care 2020;9:1287-1295. https://doi.org/10.4103/jfmpc.jfmpc_876_19. 10.4103/jfmpc.jfmpc_876_19 PMID: ; PMCID: . - DOI - PMC - PubMed
    1. Lukinovic N, Malovrh EP, Takac I, Sobocan M, Knez J. Advances in diagnostics and management of gestational trophoblastic disease. Radiol Oncol 2022;56:430-439. https://doi.org/10.2478/raon-2022-0038. 10.2478/raon-2022-0038 PMID: ; PMCID: . - DOI - PMC - PubMed

Substances